NCT04058873View on ClinicalTrials.gov

A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg

CompletedOBSERVATIONAL
Enrollment

1,980

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

October 1, 2020

Study Completion Date

November 1, 2020

Conditions
Pregnancy Related
Interventions
DRUG

Levonorgestrel 1.5mg

Levonorgestrel 1.5mg for pericoital use

Trial Locations (1)

Unknown

Marie Stopes International Ghana, Accra

Sponsors
All Listed Sponsors
collaborator

Population Council

OTHER

collaborator

Marie Stopes International

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

The Children's Investment Fund Foundation

OTHER

lead

Camber Collective

OTHER

NCT04058873 - A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg | Biotech Hunter | Biotech Hunter